(PATH) Uipath - Ratings and Ratios
Automation, Platform, Robots, AI, Cloud
PATH EPS (Earnings per Share)
PATH Revenue
Description: PATH Uipath
UiPath Inc. (NYSE:PATH) is a leading provider of robotic process automation (RPA) solutions, offering an end-to-end automation platform that enables organizations to automate repetitive tasks with precision and speed. The companys platform is equipped with embedded AI, ML, and NLP capabilities, allowing for improved decision-making and information processing.
UiPaths automation platform provides a range of features, including UI automations, API integrations, and AI-based document understanding, which can be combined in a single workflow. The companys multi-tenant platform enables enterprise deployment with security and governance, while its Automation Cloud allows for rapid automation without infrastructure overhead. Key performance indicators (KPIs) to watch include the companys revenue growth, customer acquisition rate, and automation adoption rates across various industries, such as financial services, healthcare, and manufacturing.
UiPaths customer base spans multiple sectors, including financial services, healthcare, manufacturing, retail, and public sector, providing a diversified revenue stream. To evaluate the companys performance, we can analyze KPIs such as customer retention rates, average revenue per user (ARPU), and the ratio of sales and marketing expenses to revenue. Additionally, the companys ability to expand its platforms capabilities and maintain its competitive edge in the RPA market will be crucial to its long-term success.
From a valuation perspective, UiPaths price-to-sales (P/S) ratio and enterprise value-to-EBITDA (EV/EBITDA) multiples can be compared to those of its peers in the systems software industry. Given the companys current P/E Forward multiple of 22.52, we can assess whether the stock is reasonably valued relative to its growth prospects. Furthermore, analyzing the companys return on equity (RoE) and return on assets (RoA) will provide insights into its ability to generate profits from shareholders equity and assets.
PATH Stock Overview
| Market Cap in USD | 6,148m |
| Sub-Industry | Systems Software |
| IPO / Inception | 2021-04-21 |
PATH Stock Ratings
| Growth Rating | -43.0% |
| Fundamental | 52.8% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -22.8% |
| Analyst Rating | 3.17 of 5 |
PATH Dividends
Currently no dividends paidPATH Growth Ratios
| Growth Correlation 3m | -74.5% |
| Growth Correlation 12m | -43.8% |
| Growth Correlation 5y | -74.8% |
| CAGR 5y | -6.75% |
| CAGR/Max DD 3y | -0.11 |
| CAGR/Mean DD 3y | -0.31 |
| Sharpe Ratio 12m | -0.09 |
| Alpha | -26.49 |
| Beta | 0.998 |
| Volatility | 39.81% |
| Current Volume | 9219.8k |
| Average Volume 20d | 10224.4k |
| Stop Loss | 10.9 (-4.4%) |
| Signal | -0.83 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (20.2m TTM) > 0 and > 6% of Revenue (6% = 89.8m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA -0.15pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 86.35% (prev 118.8%; Δ -32.41pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 334.7m > Net Income 20.2m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 2.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (542.9m) change vs 12m ago -4.43% (target <= -2.0% for YES) |
| Gross Margin 82.86% (prev 83.85%; Δ -0.99pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 56.55% (prev 51.18%; Δ 5.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' -1.57
| (A) 0.50 = (Total Current Assets 2.03b - Total Current Liabilities 738.4m) / Total Assets 2.59b |
| (B) -0.77 = Retained Earnings (Balance) -2.01b / Total Assets 2.59b |
| (C) -0.01 = EBIT TTM -26.2m / Avg Total Assets 2.65b |
| (D) -2.14 = Book Value of Equity -1.98b / Total Liabilities 926.6m |
| Total Rating: -1.57 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.84
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 5.50% = 2.75 |
| 3. FCF Margin 20.69% = 5.17 |
| 4. Debt/Equity 0.56 = 2.35 |
| 5. Debt/Ebitda -61.10 = -2.50 |
| 6. ROIC - WACC -10.03% = -12.50 |
| 7. RoE 1.16% = 0.10 |
| 8. Rev. Trend 73.86% = 3.69 |
| 9. Rev. CAGR 12.33% = 1.54 |
| 10. EPS Trend 29.59% = 0.74 |
| 11. EPS CAGR 49.11% = 2.50 |
What is the price of PATH shares?
Over the past week, the price has changed by -3.39%, over one month by +6.24%, over three months by -8.65% and over the past year by -8.65%.
Is Uipath a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PATH is around 9.78 USD . This means that PATH is currently overvalued and has a potential downside of -14.21%.
Is PATH a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 18
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the PATH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.3 | 16.7% |
| Analysts Target Price | 13.3 | 16.7% |
| ValueRay Target Price | 10.9 | -4.3% |
Last update: 2025-09-07 02:02
PATH Fundamental Data Overview
CCE Cash And Equivalents = 1.45b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 383.0
P/E Forward = 20.8768
P/S = 4.1076
P/B = 3.6907
P/EG = 0.5969
Beta = 1.022
Revenue TTM = 1.50b USD
EBIT TTM = -26.2m USD
EBITDA TTM = -15.2m USD
Long Term Debt = 188.2m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 738.4m USD (from totalCurrentLiabilities, last quarter)
Debt = 926.6m USD (Calculated: Short Term 738.4m + Long Term 188.2m)
Net Debt = -556.0m USD (from netDebt column, last quarter)
Enterprise Value = 5.63b USD (6.15b + Debt 926.6m - CCE 1.45b)
Interest Coverage Ratio = unknown (Ebit TTM -26.2m / Interest Expense TTM 0.0)
FCF Yield = 5.50% (FCF TTM 309.6m / Enterprise Value 5.63b)
FCF Margin = 20.69% (FCF TTM 309.6m / Revenue TTM 1.50b)
Net Margin = 1.35% (Net Income TTM 20.2m / Revenue TTM 1.50b)
Gross Margin = 82.86% ((Revenue TTM 1.50b - Cost of Revenue TTM 256.5m) / Revenue TTM)
Tobins Q-Ratio = -2.84 (set to none) (Enterprise Value 5.63b / Book Value Of Equity -1.98b)
Interest Expense / Debt = 1.96% (Interest Expense 18.1m / Debt 926.6m)
Taxrate = 52.39% (1.74m / 3.33m)
NOPAT = -26.2m (EBIT -26.2m, no tax applied on loss)
Current Ratio = 2.75 (Total Current Assets 2.03b / Total Current Liabilities 738.4m)
Debt / Equity = 0.56 (Debt 926.6m / last Quarter total Stockholder Equity 1.67b)
Debt / EBITDA = -61.10 (Net Debt -556.0m / EBITDA -15.2m)
Debt / FCF = 2.99 (Debt 926.6m / FCF TTM 309.6m)
Total Stockholder Equity = 1.74b (last 4 quarters mean)
RoA = 0.78% (Net Income 20.2m, Total Assets 2.59b )
RoE = 1.16% (Net Income TTM 20.2m / Total Stockholder Equity 1.74b)
RoCE = -1.36% (Ebit -26.2m / (Equity 1.74b + L.T.Debt 188.2m))
RoIC = -1.49% (NOPAT -26.2m / Invested Capital 1.76b)
WACC = 8.54% (E(6.15b)/V(7.07b) * Re(9.69%)) + (D(926.6m)/V(7.07b) * Rd(1.96%) * (1-Tc(0.52)))
Shares Correlation 3-Years: 29.01 | Cagr: 0.03%
Discount Rate = 9.69% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 71.90% ; FCFE base≈316.5m ; Y1≈306.2m ; Y5≈303.9m
Fair Price DCF = 8.96 (DCF Value 4.10b / Shares Outstanding 457.6m; 5y FCF grow -4.47% → 3.0% )
Revenue Correlation: 73.86 | Revenue CAGR: 12.33%
Rev Growth-of-Growth: -9.16
EPS Correlation: 29.59 | EPS CAGR: 49.11%
EPS Growth-of-Growth: 1.42
Additional Sources for PATH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle